| Matthew D Renner, MD | |
|
100 E Idaho St, Suite 400, Boise, ID 83712-6267 | |
| (208) 345-5250 | |
| Not Available |
| Full Name | Matthew D Renner |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 100 E Idaho St, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174787097 | NPI | - | NPPES |
| 1174787097 | Medicaid | ID | |
| 19627874 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD155496 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
The aetiology and clinical features of community-acquired pneumonia are different in people with chronic obstructive pulmonary disease than in those without the lung condition, Spanish research demonstrates.
An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests.
FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),
Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that, in the treatment of atrial fibrillation, surveyed European cardiologists indicate that use of vitamin K antagonists, as a class, is primarily driven by the availability of an oral formulation, overall low cost and widespread inclusion on European medical society guidelines and hospital formularies.
› Verified 2 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
The aetiology and clinical features of community-acquired pneumonia are different in people with chronic obstructive pulmonary disease than in those without the lung condition, Spanish research demonstrates.
An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests.
FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),
Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that, in the treatment of atrial fibrillation, surveyed European cardiologists indicate that use of vitamin K antagonists, as a class, is primarily driven by the availability of an oral formulation, overall low cost and widespread inclusion on European medical society guidelines and hospital formularies.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew D Renner, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2222 | Matthew D Renner, MD 100 E Idaho St, Suite 400, Boise, ID 83712-6267 Ph: (208) 345-5250 |
News Archive
The aetiology and clinical features of community-acquired pneumonia are different in people with chronic obstructive pulmonary disease than in those without the lung condition, Spanish research demonstrates.
An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests.
FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),
Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that, in the treatment of atrial fibrillation, surveyed European cardiologists indicate that use of vitamin K antagonists, as a class, is primarily driven by the availability of an oral formulation, overall low cost and widespread inclusion on European medical society guidelines and hospital formularies.
› Verified 2 days ago
Cristin C Slater, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 111 Main St, #100, Boise, ID 83702 Phone: 208-342-5900 Fax: 208-342-2088 | |
Maryalice Lopez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 333 N 1st St Ste 240, Boise, ID 83702 Phone: 208-338-8900 | |
Martha H Lund, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6140 Curtisian Ave, Suite 100, Boise, ID 83704 Phone: 208-367-4224 Fax: 208-367-7806 | |
Dr. B Kerry Lowder, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Suite 400, Boise, ID 83712 Phone: 208-345-5250 Fax: 208-345-2364 | |
Dr. Michael F Koszalka Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 N 1st St Ste 150, Boise, ID 83702 Phone: 208-381-3088 | |
Dr. Juliana L Digiosia, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1072 N Liberty St, Suite 100, Boise, ID 83704 Phone: 208-302-1200 Fax: 208-302-1255 | |
Kathleen C. Keating, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St Ste 400, Boise, ID 83712 Phone: 208-345-5250 |